Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy for Clinically Node Negative HER2 Positive and Triple Negative Breast Cancer: A Pooled Analysis.

Alamoodi, Munaser; Wazir, Umar; Mokbel, Kinan; Patani, Neill; Varghese, Jajini; Mokbel, Kefah

Alamoodi, Munaser; Wazir, Umar; Mokbel, Kinan; Patani, Neill; Varghese, Jajini; Mokbel, Kefah.

Afiliação

Alamoodi M; Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Wazir U; The London Breast Institute, Princess Grace Hospital, London W1U 5NY, UK.
Mokbel K; The London Breast Institute, Princess Grace Hospital, London W1U 5NY, UK.
Patani N; Department of Surgery, Khyber Teaching Hospital, Peshawar 25120, Pakistan.
Varghese J; The London Breast Institute, Princess Grace Hospital, London W1U 5NY, UK.
Mokbel K; College of Medicine and Health, University of Exeter Medical School, Exeter EX1 2LU, UK.

Cancers (Basel) ; 15(13)2023 Jun 24.

Article em En | MEDLINE | ID: mdl-37444434

Palavras-chave

breast cancer; clinically node negative; complete pathological response; complete radiological response; neoadjuvant systemic chemotherapy; pathological node negative; pathological node positive; sentinel lymph node biopsy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Arábia Saudita

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google